UBS Reiterates Neutral Rating on Allegiant Travel Company (ALGT)
Rating Change UBS analysts reiterated a Neutral rating on Allegiant Travel Company (NASDAQ:ALGT) on August 05, 2026. Market Context Allegiant Travel Company operates in the…
Read moreReal-time context
Upgrades, downgrades, initiations, and price-target changes.
Rating Change UBS analysts reiterated a Neutral rating on Allegiant Travel Company (NASDAQ:ALGT) on August 05, 2026. Market Context Allegiant Travel Company operates in the…
Read moreRating Change HC Wainwright & Co. analysts reiterated a Buy rating on Zymeworks Inc. (NASDAQ:ZYME) on August 05, 2026.
Read moreRating Change Wells Fargo analysts reiterated a Equal-Weight rating on LeMaitre Vascular, Inc. (NASDAQ:LMAT) on August 05, 2026. Market Context LeMaitre Vascular, Inc.
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Addus HomeCare Corporation (NASDAQ:ADUS) on August 05, 2026. Market Context Addus HomeCare Corporation…
Read moreRating Change Piper Sandler analysts reiterated a Overweight rating on Twist Bioscience Corporation (NASDAQ:TWST) on August 05, 2026. Market Context Twist Bioscience Corporation…
Read moreRating Change Benchmark analysts reiterated a Buy rating on Pinnacle Financial Partners, Inc. (NASDAQ:PNFPP) on August 05, 2026. Market Context Pinnacle Financial Partners, Inc.
Read moreRating Change Guggenheim analysts reiterated a Buy rating on Travere Therapeutics, Inc. (NASDAQ:TVTX) on August 05, 2026. Market Context Travere Therapeutics, Inc.
Read moreRating Change TD Cowen analysts reiterated a Buy rating on Travere Therapeutics, Inc. (NASDAQ:TVTX) on August 05, 2026. Market Context Travere Therapeutics, Inc.
Read moreRating Change Citigroup analysts reiterated a Buy rating on Travere Therapeutics, Inc. (NASDAQ:TVTX) on August 05, 2026. Market Context Travere Therapeutics, Inc.
Read moreRating Change Evercore ISI Group analysts reiterated a Outperform rating on Travere Therapeutics, Inc. (NASDAQ:TVTX) on August 05, 2026. Market Context Travere Therapeutics, Inc.
Read moreRating Change Barclays analysts reiterated a Underweight rating on Intapp, Inc. (NASDAQ:INTA) on August 05, 2026. Market Context Intapp, Inc.
Read moreRating Change Truist Securities analysts reiterated a Buy rating on Intapp, Inc. (NASDAQ:INTA) on August 05, 2026. Market Context Intapp, Inc.
Read moreRating Change Piper Sandler analysts reiterated a Neutral rating on Intapp, Inc. (NASDAQ:INTA) on August 05, 2026. Market Context Intapp, Inc.
Read moreRating Change TD Cowen analysts reiterated a Hold rating on BellRing Brands, Inc. (NYSE:BRBR) on August 05, 2026. Market Context BellRing Brands, Inc.
Read moreRating Change DA Davidson analysts reiterated a Buy rating on BellRing Brands, Inc. (NYSE:BRBR) on August 05, 2026. Market Context BellRing Brands, Inc.
Read moreRating Change Oppenheimer analysts reiterated a Perform rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) on August 05, 2026. Market Context ACADIA Pharmaceuticals Inc.
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) on August 05, 2026. Market Context ACADIA Pharmaceuticals Inc.
Read moreRating Change Citizens analysts reiterated a Market Outperform rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) on August 05, 2026. Market Context ACADIA Pharmaceuticals Inc.
Read moreRating Change Piper Sandler analysts reiterated a Overweight rating on TransMedics Group, Inc. (NASDAQ:TMDX) on August 05, 2026. Market Context TransMedics Group, Inc.
Read moreRating Change Piper Sandler analysts reiterated a Neutral rating on Vornado Realty Trust (NYSE:VNO) on August 05, 2026. Market Context Vornado Realty Trust operates in the Real…
Read more